Next 10 |
2024-05-13 03:56:51 ET Summary Hologic's women's health business benefited from the pandemic but is now facing headwinds that will end in 2024. The company has a strong balance sheet, solid track record, and reasonable valuation, making it an attractive investment. Hologic rec...
2024-05-02 23:24:08 ET Call Start: 16:30 Call End: 17:24 Hologic, Inc. (HOLX) Q2 2024 Earnings Conference Call May 2, 2024 16:30 ET Company Participants Ryan Simon - Vice President, Investor Relations Steve MacMillan - Chairman, President & Chief Executiv...
2024-05-02 16:05:05 ET Read the full article on Seeking Alpha For further details see: Hologic Non-GAAP EPS of $1.03 beats by $0.05, revenue of $1.02B beats by $20M
– Revenue of $1,017.8 Million, GAAP Diluted EPS of $0.72, and Non-GAAP Diluted EPS of $1.03; Revenue and Non-GAAP Diluted EPS Exceeded Guidance – – Total Company Organic Revenue Growth Excluding COVID-19 of 4.9% in Constant Currency; Against a 21.9% Prior Year Period Comp...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
2024-05-01 17:20:29 ET More on Hologic Hologic: Prospects For Growth As Headwinds Disappear Hologic, Inc. (HOLX) Q1 2024 Results - Earnings Call Transcript Hologic digital cytology system wins FDA approval Hologic Non-GAAP EPS of $0.98 beats by $0.03, revenue...
2024-04-29 16:17:17 ET More on Hologic Hologic: Prospects For Growth As Headwinds Disappear Hologic digital cytology system wins FDA approval Hologic Non-GAAP EPS of $0.98 beats by $0.03, revenue of $1.01B beats by $26.42M Seeking Alpha’s Quant Rating ...
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag®), a privately held developer of breast cancer surgery technologies, for approximately $310 million, subject to working capital ...
2024-04-22 13:23:08 ET Goldman Sachs analysts rebalanced their “buybacks basket” as 2024 buyback growth is forecasted to be 13%.... Read the full article on Seeking Alpha For further details see: Goldman’s buybacks basket: Buyback growth will be 13% in 2024
2024-04-18 08:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Although technology an...
News, Short Squeeze, Breakout and More Instantly...
– Revenue of $1,017.8 Million, GAAP Diluted EPS of $0.72, and Non-GAAP Diluted EPS of $1.03; Revenue and Non-GAAP Diluted EPS Exceeded Guidance – – Total Company Organic Revenue Growth Excluding COVID-19 of 4.9% in Constant Currency; Against a 21.9% Prior Year Period Comp...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag®), a privately held developer of breast cancer surgery technologies, for approximately $310 million, subject to working capital ...